Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing data from Myeloid Leukaemia of Down Syndrome (ML-DS)

ABSTRACT: RNA sequencing data from Myeloid Leukaemia of Down Syndrome (ML-DS)

PROVIDER: PRJEB32403 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR3305910_1.fastq.gz	Fastqsanger.gz
	ERR3305910_2.fastq.gz	Fastqsanger.gz
	ERR3305911_1.fastq.gz	Fastqsanger.gz
	ERR3305911_2.fastq.gz	Fastqsanger.gz
	ERR3305912_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

RNA sequencing data from Myeloid Leukaemia of Down Syndrome (ML-DS)

Project description:Paired-end 150bp RNA sequencing data from ML-DS samples.

2020-12-31 | E-MTAB-7932 | biostudies-arrayexpress

Transcriptomic profiling of 2 cell lines from Down-Syndrome children with Acute Lymphoblastic Leukaemia (DS-ALL)

Project description:Two cell lines derived from 2 Down Syndrome children who developed Acute Lymphoblastic Leukaemia were profiled at the transcriptomic level (bulk RNAseq) and compared against their Patient-Derived Xenograft (PDX) of origin.

2024-07-10 | GSE245056 | GEO

Multiplexed DNA high throughput genotyping study to determine the mutational status of transient (TAM) and acute myeloid leukaemic (ML-DS) Down syndrome individuals.

Project description:We used a 48.48 Fluidigm Access Array approach (1070 Amplicons spanning 62 genes: 157kB coverage) of genomic DNA from over 100 samples to genotype individuals with transient abnormal myelopoiesis (TAM) and acute myeloid leukemia of Down syndrome (ML-DS). Individually barcoded patient samples were subjected to paired-end 150bp sequencing (Illumina MiSeq), including paired GATA1 variant negative controls (including Post treatment) and 8 known reference GATA1- controls. Samples were mapped to build 37 of the human reference genome and subject to bioinformatic analysis (Varscan, Pindel, GATK) to facilitate the characterisation of known gene mutations in cancer as well as the identification / validation of potentially novel variants.

2019-07-17 | E-MTAB-7729 | biostudies-arrayexpress

Murine ML-DS-like leukemias

Project description:Modelling the progression from TAM to ML-DS in children with Down syndrome utilizing a murine transplantation model

| PRJEB30376 | ENA

Transcriptomic profiling of 2 cell lines from Down-Syndrome children with Acute Lymphoblastic Leukaemia (DS-ALL)

Project description:Transcriptomic profiling of 2 cell lines from Down-Syndrome children with Acute Lymphoblastic Leukaemia (DS-ALL)

| PRJNA1026868 | ENA

Single cell genotyping of Myeloid Leukaemia of Down Syndrome cells

Project description:Single cells from ML-DS sample 186-2 (bone marrow) were analysed to determine whether mutations in JAK2 and CSF2RB ocurred in the same or different cells in this patient. Single live, CD19neg, CD3neg, CD45mid and CD117 positive cells were sorted into 96-well plates on the BD Fusion with antibodies as described above. Cord blood single cells were sorted similarly to serve as a control for the single cell Sequencing.

2020-12-31 | E-MTAB-7935 | biostudies-arrayexpress

INCLUDE: Mechanisms, Genomic Risk Stratification and Precision Intervention for Acute Myeloid Leukemia in Children with Down syndrome (ML-DS)

Project description:INCLUDE: Mechanisms, Genomic Risk Stratification and Precision Intervention for Acute Myeloid Leukemia in Children with Down syndrome (ML-DS)

| PRJNA854740 | ENA

Single cell genotyping of Myeloid Leukaemia of Down Syndrome cells

Project description:Single cell genotyping of Myeloid Leukaemia of Down Syndrome cells

| PRJEB32618 | ENA

Gene expression profiling of Down Syndrome (DS)-AMKL and non-DS AMKL samples

Project description:The goal of this study is to define a gene expression signature unique to DS-AMKL (acute megakaryoblastic leukemia or FAB M7 leukemia). A similar study was done previously, but using unfractionated patient leukemic samples. In this study, we sorted megakaryocytic leukemia blasts from patients and then compared their gene expression signatures to those from similarly sorted blasts from patients with non-DS AMKL. This allowed us to identify a gene expression signature more unique to DS-AMKL samples.

2010-08-01 | GSE16677 | GEO

Multiplexed DNA high throughput genotyping study to determine the mutational status of transient (TAM) and acute myeloid leukaemic (ML-DS) Down syndrome individuals.

Project description:Multiplexed DNA high throughput genotyping study to determine the mutational status of transient (TAM) and acute myeloid leukaemic (ML-DS) Down syndrome individuals.

| PRJEB31641 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data